FlowCardia

FlowCardia, Inc. is a medical device company established in 2002 with the aim of designing and developing a series of innovative catheter technologies to facilitate guidewire crossing in totally occluded coronary and peripheral arteries. Chronic Total Occlusion (CTO) is considered one of the last major clinical challenges in interventional therapy. The historical lack of safe and effective CTO recanalization devices is a primary reason why a significant number of patients still undergo coronary and peripheral bypass surgeries or lower limb amputations.